BR0112915A - Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione derivative - Google Patents

Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione derivative

Info

Publication number
BR0112915A
BR0112915A BR0112915-5A BR0112915A BR0112915A BR 0112915 A BR0112915 A BR 0112915A BR 0112915 A BR0112915 A BR 0112915A BR 0112915 A BR0112915 A BR 0112915A
Authority
BR
Brazil
Prior art keywords
phenoxyalkyl
pharmaceutical composition
metformin
thiazolidinedione derivative
type
Prior art date
Application number
BR0112915-5A
Other languages
Portuguese (pt)
Inventor
Gerard Moinet
Gerard Botton
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0112915A publication Critical patent/BR0112915A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA COMPREENDENDO METFORMINA E UM DERIVADO DO TIPO 5-FENOXIALQUIL-2,4-TIAZOLIDINADIONA". A presente invenção refere-se a uma composição farmacêutica compreendendo, como ingredientes ativos, metformina optativamente na forma de seus sais farmaceuticamente aceitáveis e uma derivado do tipo de 5-fenoxialquil-2,4-tiazolidinadiona."PHARMACEUTICAL COMPOSITION UNDERSTANDING METFORMINE AND A TYPE OF 5-PHENOXYALKYL-2,4-TIAZOLIDINATION TYPE". The present invention relates to a pharmaceutical composition comprising as active ingredients metformin optionally in the form of pharmaceutically acceptable salts thereof and a 5-phenoxyalkyl-2,4-thiazolidinedione type derivative.

BR0112915-5A 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione derivative BR0112915A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010362A FR2812547B1 (en) 2000-08-04 2000-08-04 PHARMACEUTICAL COMPOSITION COMPRISING A METFORMIN AND THIAZOLIDINEDIONION DERIVATIVE AND ITS USE FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
PCT/EP2001/008512 WO2002011721A1 (en) 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative

Publications (1)

Publication Number Publication Date
BR0112915A true BR0112915A (en) 2003-07-08

Family

ID=8853342

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112915-5A BR0112915A (en) 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione derivative

Country Status (19)

Country Link
US (1) US20040014797A1 (en)
EP (1) EP1305025A1 (en)
JP (1) JP2004505915A (en)
KR (1) KR20030019470A (en)
CN (1) CN1446090A (en)
AR (1) AR030309A1 (en)
AU (1) AU2001282010A1 (en)
BR (1) BR0112915A (en)
CA (1) CA2417883A1 (en)
CZ (1) CZ2003476A3 (en)
EC (1) ECSP034463A (en)
FR (1) FR2812547B1 (en)
HU (1) HUP0303684A2 (en)
MX (1) MXPA03000975A (en)
NO (1) NO20030518D0 (en)
PL (1) PL358791A1 (en)
RU (1) RU2003105809A (en)
SK (1) SK2082003A3 (en)
WO (1) WO2002011721A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100897890B1 (en) 2002-06-17 2009-05-18 인벤티아 헬스케어 피브이티. 엘티디. Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) * 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
EP2046284A1 (en) * 2006-08-04 2009-04-15 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
US8058312B2 (en) 2007-01-29 2011-11-15 Hanall Biopharma Co., Ltd. N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749583B1 (en) * 1996-06-07 1998-08-21 Lipha NOVEL SUBSTITUTED THIAZOLIDINE -2,4- DIONE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
AU8539398A (en) * 1997-06-18 1999-01-04 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and metformin
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment

Also Published As

Publication number Publication date
HUP0303684A2 (en) 2004-03-01
FR2812547B1 (en) 2002-10-31
EP1305025A1 (en) 2003-05-02
ECSP034463A (en) 2003-03-31
US20040014797A1 (en) 2004-01-22
MXPA03000975A (en) 2003-06-09
KR20030019470A (en) 2003-03-06
PL358791A1 (en) 2004-08-23
CA2417883A1 (en) 2002-02-14
CZ2003476A3 (en) 2003-06-18
AR030309A1 (en) 2003-08-20
FR2812547A1 (en) 2002-02-08
RU2003105809A (en) 2004-08-27
WO2002011721A1 (en) 2002-02-14
NO20030518L (en) 2003-02-03
NO20030518D0 (en) 2003-02-03
CN1446090A (en) 2003-10-01
JP2004505915A (en) 2004-02-26
SK2082003A3 (en) 2003-07-01
AU2001282010A1 (en) 2002-02-18

Similar Documents

Publication Publication Date Title
BR0214403A (en) Pharmaceutical compositions comprising metformin and glyburide for the treatment of type 2 diabetes mellitus
BRPI0608178A2 (en) aminopyrazole derivatives, their manufacture, pharmaceutical composition and use as pharmaceutical agents
PA8591701A1 (en) PIRROLOPIRIMIDINE DERIVATIVES
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
BR0113331A (en) Phenylalanine derivatives or pharmaceutically acceptable salts thereof, alpha 4 integrin antagonist, therapeutic agent or preventive agent for inflammatory diseases, and pharmaceutical composition
BRPI0407306A (en) HIV-inhibiting 1,2,4-triazines
BR0111263A (en) 2-Aminocarbonyl-9h-purine derivatives
MXPA03005464A (en) Antiviral agents.
BR9907866A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines to reduce hyperglycemia
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
AR054347A1 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
BRPI0414428A (en) pharmaceutical compositions
DOP2005000039A (en) HYDROCHLORIDE OF [4- (5-AMINOMETIL-2-FLUORO-PHENYL) - PIPERIDIN-1-IL] - (4-BOMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE
BRPI0408437A (en) substituted p-diaminobenzene derivatives, pharmaceutical composition, and use thereof
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
BR0212069A (en) Oral antidiabetic agents
BR0210912A (en) Compounds and compositions as cathepsin inhibitors
BRPI0408136A (en) nitrogen-containing heterocyclic derivatives having 2,6-disubstituted styryl
BR0116060A (en) Dronedarone pharmaceutical composition for parenteral administration
WO2006031719A3 (en) 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof
BRPI0411702B8 (en) use of hyaluronic acid to prepare compositions for the treatment of thrush of the oral cavity
BR0112915A (en) Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione derivative
BR0318659A (en) proline derivatives used as active pharmaceutical ingredients in the treatment of tumors
ES2150404T1 (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITOZOXANIDE.
AR036009A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]